Genmark Diagnostics reported $-2087000 in EBIT for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 1862M 248M
Agilent A:US $ 351M 33M
Bruker BRKR:US $ 89.6M 3.5M
Danaher DHR:US $ 2005M 8M
Genmark Diagnostics GNMK:US $ -2087000 821K
Hologic HOLX:US $ 362.2M 421.5M
Illumina ILMN:US $ 187M 6M
Laboratory Of America LH:US $ 750M 338.6M
Luminex LMNX:US $ 13.46M 2.96M
Mesa Laboratories MLAB:US $ 3.12M 1.26M
Myriad Genetics MYGN:US $ -19000000 27.7M
Nanostring Technologies NSTG:US $ -25635000 233K
Orasure Technologies OSUR:US $ 1.58M 8.04M
Oxford Immunotec Global OXFD:US 275K 10.11M
Pacific Biosciences Of California PACB:US $ -37573000 3.86M
Perkinelmer PKI:US $ 323.32M 164.31M
Quest Diagnostics DGX:US $ 554M 127M
Quidel QDEL:US $ 24.33M 200.58M
Siemens SIE:GR 1.72B 30M
Thermo Fisher Scientific TMO:US $ 2282M 805M
Veracyte VCYT:US $ 1.23M 11.54M
Waters WAT:US $ 195.85M 24.58M